Zongertinib has been granted accelerated approval in NSCLC harboring HER2 TKD mutations as part of the Commissioner’s National Priority Voucher pilot program.

Treatment with systemic intravenous olvimulogene nanivacirepvec (Olvi-Vec) led to promising preliminary results in patients ...

The FDA has approved encorafenib plus cetuximab and fluorouracil-based chemotherapy in patients with BRAF v600E-positive metastatic colorectal cancer. The FDA has approved encorafenib (Braftovi) ...

Clinical use cases include AI-assisted palliative-care triage, consolidating EHR signals to surface unmet supportive needs, and ambient listening that drafts notes for nurse verification and workload ...

Deborah (Debi) A. Boyle MSN, RN, AOCNS, FAAN, is editor in chief of Oncology Nursing News®. She is a long tenured oncology clinical nurse specialist who has practiced in both Comprehensive Cancer ...